Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

45
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
11/21/2014 11/24/2014 11/25/2014 11/26/2014 11/27/2014 Date
78.54(c) 78.89(c) 78.05(c) 78.92(c) 80.4 Last
843 147 386 902 604 992 466 931 458 187 Volume
+0.95% +0.45% -1.06% +1.11% +1.88% Change
More quotes
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore.The Merck Serono division is biopharmaceutical division which markets both chemical and... 
Sector
Pharmaceuticals
Calendar
03/03Earnings Release
Surperformance© rating of Merck KGaA
Trading Rating : Investor Rating :
More about the company
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 11 305 M
EBIT 2014 2 878 M
Net income 2014 1 378 M
Debt 2014 1 483 M
Yield 2014 1,33%
Sales 2015 12 110 M
EBIT 2015 2 462 M
Net income 2015 1 470 M
Finance 2015 93,8 M
Yield 2015 1,41%
PER 2014 26,03
PER 2015 23,51
EV / Sales 2014 1,03x
EV / Sales 2015 0,83x
Capitalization 10 200 M
More Financials
Latest news on MERCK KGAA
1d ago MERCK KGAA : Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer..
1d ago MERCK KGAA : Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to..
2d ago MERCK KGAA : Darmstadt, Germany, Commissions Biomass Energy Plant in India
2d ago MERCK KGAA : Commissions Biomass Energy Plant in India
2d ago MERCK KGAA : EMD Millipore Assigned Patent
6d ago MERCK KGAA : Maintenance Agreement Renewal Sought by Health and Human Services
11/18 Pfizer, Merck strike $2.85B deal as hope of AstraZeneca merger wanes
11/18DJLONDON MARKETS : AstraZeneca Advances In London; Pound Rises As Inflation Ticks ..
11/18 MERCK KGAA : EMD Millipore Assigned Patent
11/18 AstraZeneca trumpets solo strength in cancer drugs post Pfizer struggle
11/17DJStocks Close Higher, With S&P Hitting Another Record High
11/17 Pfizer dampens Astra bid hopes with German Merck cancer deal
More news
4-Traders Strategies on MERCK KGAA 
04/10Prices move higher as positive news are released
03/10A gap-filling is anticipated
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF